Impact of Adjuvant Radiotherapy on Survival of Patients with Stage I-II Endometrial Cancer
A Systematic Review
DOI:
https://doi.org/10.56226/150Keywords:
Endometrial Cancer, Adjuvant Radiotherapy, Vaginal Brachytherapy, Gynecologic Oncology, SurvivalAbstract
Introduction: Endometrial cancer is the most common gynecological neoplasm in developed countries. Most cases are diagnosed early, and surgical treatment is usually curative. The role of adjuvant radiotherapy is controversial, especially for patients with intermediate or high-risk factors. The increasing variety of therapies and emphasis on personalized treatment underscore the need to critically assess the impact of radiotherapy on patient outcomes. Therefore, this study aims to evaluate the impact of adjuvant radiotherapy on clinical outcomes in patients with endometrial cancer who have intermediate or high-risk factors.
Methods: The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The protocol was registered on the PROSPERO platform. A literature search was conducted in PubMed/MEDLINE, Embase, Scopus, Web of Science, Lilacs, and SciELO. The search covered publications up to August 2025. Controlled descriptors (MeSH) and free keywords were used, combined with Boolean operators. Original studies with clinical data on patients undergoing adjuvant radiotherapy, published in Portuguese, English, or Spanish, were included.
Results: After screening and evaluating the full texts, 12 studies were included, totaling 18,975 patients. The studies analyzed different radiotherapy modalities, such as external beam radiotherapy, vaginal brachytherapy, and combination therapy with chemotherapy. The results demonstrated that adjuvant radiotherapy significantly contributes to reducing locoregional recurrence and improving disease-free survival, especially in patients with risk factors such as high tumor grade, lymphovascular invasion, or malignant peritoneal cytology. Vaginal brachytherapy showed similar efficacy to external beam radiotherapy in many cases, with less toxicity. Recent studies propose selective treatment deintensification and the use of molecular profiles to guide radiotherapy indications, as evidenced in the PORTEC-4a clinical trial.
Conclusions: Adjuvant radiotherapy plays a relevant role in the management of early-stage endometrial cancer and should be indicated selectively based on clinical, histological, and molecular criteria.
References
Akingbade, A., Fabi, F., Cartes, R., Tsui, J., & Alfieri, J. (2024). Adjuvant Treatment of Stage I-II Serous Endometrial Cancer: A Single Institution 20-Year Experience. Current oncology (Toronto, Ont.), 31(7), 3758–3770. https://doi.org/10.3390/curroncol31070277
Arslan, S. A., Avcı, G. G., Akkas, E. A., & Guney, Y. (2020). Improved disease-free survival with adjuvant radiotherapy in early-stage endometrial cancer: 10-year outcome analysis. Journal of contemporary brachytherapy, 12(6), 572–578. https://doi.org/10.5114/jcb.2020.101690
Bollen, H., van der Veen, J., Laenen, A., & Nuyts, S. (2021). Recurrence Patterns After IMRT/VMAT in Head and Neck Cancer. Frontiers in oncology, 11, 720052. https://doi.org/10.3389/fonc.2021.720052
Chen, J. J., Shah, J. L., Harris, J. P., Bui, T. T., Schaberg, K., Kong, C. S., Kaplan, M. J., Divi, V., Schoppy, D., Le, Q. T., & Hara, W. Y. (2017). Clinical Outcomes in Elderly Patients Treated for Oral Cavity Squamous Cell Carcinoma. International journal of radiation oncology, biology, physics, 98(4), 775–783. https://doi.org/10.1016/j.ijrobp.2017.03.017
Cibula, D., Raspollini, M. R., Planchamp, F., Centeno, C., Chargari, C., Felix, A., Fischerová, D., Jahnn-Kuch, D., Joly, F., Kohler, C., Lax, S., Lorusso, D., Mahantshetty, U., Mathevet, P., Naik, R., Nout, R. A., Oaknin, A., Peccatori, F., Persson, J., Querleu, D., … Lindegaard, J. (2023). ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 33(5), 649–666. https://doi.org/10.1136/ijgc-2023-004429
Concin, N., Matias-Guiu, X., Cibula, D., Colombo, N., Creutzberg, C. L., Ledermann, J., Mirza, M. R., Vergote, I., Abu-Rustum, N. R., Bosse, T., Chargari, C., Espenel, S., Fagotti, A., Fotopoulou, C., Gatius, S., González-Martin, A., Lax, S., Levy, B., Lorusso, D., Macchia, G., … Nout, R. A. (2025). ESGO-ESTRO-ESP guidelines for the management of patients with endometrial carcinoma: update 2025. The Lancet. Oncology, 26(8), e423–e435. https://doi.org/10.1016/S1470-2045(25)00167-6
Creutzberg, C. L., & Nout, R. A. (2011). The role of radiotherapy in endometrial cancer: current evidence and trends. Current oncology reports, 13(6), 472–478. https://doi.org/10.1007/s11912-011-0191-y
Dallaire Nantel, L., Renaud, M. C., Gregoire, J., Sebastianelli, A., & Plante, M. (2021). High-grade endometrial carcinoma limited to the endometrium or a polyp: is adjuvant treatment necessary?. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 31(10), 1335–1340. https://doi.org/10.1136/ijgc-2021-002771
de Boer, S. M., Nout, R. A., Jürgenliemk-Schulz, I. M., Jobsen, J. J., Lutgens, L. C., van der Steen-Banasik, E. M., Mens, J. W., Slot, A., Stenfert Kroese, M. C., Oerlemans, S., Putter, H., Verhoeven-Adema, K. W., Nijman, H. W., & Creutzberg, C. L. (2015). Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial. International journal of radiation oncology, biology, physics, 93(4), 797–809. https://doi.org/10.1016/j.ijrobp.2015.08.023
Gadducci, A., Multinu, F., De Vitis, L. A., Cosio, S., Carinelli, S., & Aletti, G. D. (2023). Endometrial stromal tumors of the uterus: Epidemiology, pathological and biological features, treatment options and clinical outcomes. Gynecologic oncology, 171, 95–105. https://doi.org/10.1016/j.ygyno.2023.02.009
Garzon, S., Grassi, T., Mariani, A., Kollikonda, S., Weaver, A. L., McGree, M. E., Petersen, I. A., Weroha, S. J., Glaser, G. E., Langstraat, C. L., Amarnath, S. R., & AlHilli, M. M. (2022). Not all stage I and II endometrial cancers are created equal: Recurrence-free survival and cause-specific survival after observation or vaginal brachytherapy alone in all subgroups of early-stage high-intermediate and high-risk endometrial cancer. Gynecologic oncology, 167(3), 444–451. https://doi.org/10.1016/j.ygyno.2022.10.004
Goel, P., Singh, V., Sharma, R., Chaudhary, D., Chatterjee, A., Dora, T., Sancheti, S., Goel, A., Khandelwal, S., Sali, A. P., Kaur, H., Guru, A., & Kapoor, R. (2023). Early endometrial carcinoma: Experience and outcomes. Journal of cancer research and therapeutics, 19(Supplement), S0. https://doi.org/10.4103/jcrt.jcrt_920_21
Holloway, R. W., Abu-Rustum, N. R., Backes, F. J., Boggess, J. F., Gotlieb, W. H., Jeffrey Lowery, W., Rossi, E. C., Tanner, E. J., & Wolsky, R. J. (2017). Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations. Gynecologic oncology, 146(2), 405–415. https://doi.org/10.1016/j.ygyno.2017.05.027
Instituto Nacional de Câncer José Alencar Gomes da Silva. (2022). Estimativa 2023: Incidência do câncer no Brasil. INCA. https://www.gov.br/inca/pt-br/assuntos/cancer/numeros/estimativa
Keys, H. M., Roberts, J. A., Brunetto, V. L., Zaino, R. J., Spirtos, N. M., Bloss, J. D., Pearlman, A., Maiman, M. A., Bell, J. G., & Gynecologic Oncology Group (2004). A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecologic oncology, 92(3), 744–751. https://doi.org/10.1016/j.ygyno.2003.11.048
Latif, N. A., Haggerty, A., Jean, S., Lin, L., & Ko, E. (2014). Adjuvant therapy in early-stage endometrial cancer: a systematic review of the evidence, guidelines, and clinical practice in the U.S. The oncologist, 19(6), 645–653. https://doi.org/10.1634/theoncologist.2013-0475
Lee, G., Aitelli, A., Niemierko, A., Lamba, N., Kim, D. W., Curry, W. T., Oh, K. S., Barker, F. G., 2nd, & Shih, H. A. (2025). Toxicities Associated with Adjuvant Radiation Therapy in Atypical Meningioma. Advances in radiation oncology, 10(3), 101726. https://doi.org/10.1016/j.adro.2025.101726
Martínez, A., Chargari, C., Kalbacher, E., Gaillard, A. L., Leary, A., Koskas, M., Chopin, N., Serre, A. A., Hardy-Bessard, A. C., Akladios, C., & Lecuru, F. (2023). Recommandations pour la pratique clinique Nice/Saint-Paul-de-Vence 2022–2023 : prise en charge du cancer de l'endomètre localisé. Bulletin du cancer, 110(6S), 6S20–6S33. https://doi.org/10.1016/S0007-4551(23)00331-4
Matsuo, K., Matsuzaki, S., Nusbaum, D. J., Roman, L. D., Wright, J. D., Harter, P., & Klar, M. (2021). Association Between Adjuvant Therapy and Survival in Stage II-III Endometrial Cancer: Influence of Malignant Peritoneal Cytology. Annals of surgical oncology, 28(12), 7591–7603. https://doi.org/10.1245/s10434-021-09900-4
Morén, B., Larsson, T., & Tedgren, Å. C. (2021). Optimization in treatment planning of high dose-rate brachytherapy - Review and analysis of mathematical models. Medical physics, 48(5), 2057–2082. https://doi.org/10.1002/mp.14762
Muffly, L. S., Parsons, H. M., Miller, K., Li, Q., Brunson, A., & Keegan, T. H. (2023). Impact of Specialized Treatment Setting on Survival in Adolescent and Young Adult ALL. JCO oncology practice, 19(12), 1190–1198. https://doi.org/10.1200/OP.23.00373
Narasimhulu, D. M., Cope, A., Riaz, I. B., Petersen, I., Cilby, W., Langstraat, C., Glaser, G., Kumar, A., Cappuccio, S., Murad, M. H., West, C., & Mariani, A. (2020). External beam radiotherapy versus vaginal brachytherapy in patients with stage II endometrial cancer: a systematic review and meta-analysis. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 30(6), 797–805. https://doi.org/10.1136/ijgc-2020-001199
Nout, R. A., Smit, V. T., Putter, H., Jürgenliemk-Schulz, I. M., Jobsen, J. J., Lutgens, L. C., van der Steen-Banasik, E. M., Mens, J. W., Slot, A., Kroese, M. C., van Bunningen, B. N., Ansink, A. C., van Putten, W. L., Creutzberg, C. L., & PORTEC Study Group (2010). Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet (London, England), 375(9717), 816–823. https://doi.org/10.1016/S0140-6736(09)62163-2
Paulson, K., Logie, N., Han, G., Tilley, D., Menon, G., Menon, A., Nelson, G., Phan, T., Murray, B., Ghosh, S., Pearcey, R., Huang, F., & Wiebe, E. (2023). Adjuvant Radiotherapy in Stage II Endometrial Cancer: Selective De-intensification of Adjuvant Treatment. Clinical oncology (Royal College of Radiologists (Great Britain)), 35(1), e94–e102. https://doi.org/10.1016/j.clon.2022.08.034
Poitevin-Chacón, A., & Hinojosa-Gómez, J. (2012). Patterns of care of radiotherapy in México. Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 18(2), 57–60. https://doi.org/10.1016/j.rpor.2012.09.001
Randall, M. E., Filiaci, V., McMeekin, D. S., von Gruenigen, V., Huang, H., Yashar, C. M., Mannel, R. S., Kim, J. W., Salani, R., DiSilvestro, P. A., Burke, J. J., Rutherford, T., Spirtos, N. M., Terada, K., Anderson, P. R., Brewster, W. R., Small, W., Aghajanian, C. A., & Miller, D. S. (2019). Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 37(21), 1810–1818. https://doi.org/10.1200/JCO.18.01575
Ren, K., Wang, W., Sun, S., Hou, X., Hu, K., & Zhang, F. (2022). Recurrent patterns after postoperative radiotherapy for early stage endometrial cancer: A competing risk analysis model. Cancer medicine, 11(1), 257–267. https://doi.org/10.1002/cam4.4423
Ren, K., Wang, W., Sun, S., Wang, D., Liu, X., Hou, X., Hu, K., & Zhang, F. (2022). Recurrence Features and Factors influencing Post-relapse Survival in Early-stage Endometrial Cancer after Adjuvant Radiotherapy. Journal of Cancer, 13(1), 202–211. https://doi.org/10.7150/jca.65246
Saldi, S., Bellavita, R., Lancellotta, V., Palumbo, I., Lupattelli, M., Chierchini, S., Falcinelli, L., Zucchetti, C., Bini, V., & Aristei, C. (2019). Acute Toxicity Profiles of Hypofractionated Adjuvant and Salvage Radiation Therapy After Radical Prostatectomy: Results of a Prospective Study. International journal of radiation oncology, biology, physics, 103(1), 105–111. https://doi.org/10.1016/j.ijrobp.2018.08.016
Sloboda R. S. (1992). Optimization of brachytherapy dose distributions by simulated annealing. Medical physics, 19(4), 955–964. https://doi.org/10.1118/1.596783
van den Heerik, A. S. V. M., Horeweg, N., Creutzberg, C. L., & Nout, R. A. (2022). Vaginal brachytherapy management of stage I and II endometrial cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 32(3), 304–310. https://doi.org/10.1136/ijgc-2021-002493
van den Heerik, A. S. V. M., Horeweg, N., Nout, R. A., Lutgens, L. C. H. W., van der Steen-Banasik, E. M., Westerveld, G. H., van den Berg, H. A., Slot, A., Koppe, F. L. A., Kommoss, S., Mens, J. W. M., Nowee, M. E., Bijmolt, S., Cibula, D., Stam, T. C., Jurgenliemk-Schulz, I. M., Snyers, A., Hamann, M., Zwanenburg, A. G., Coen, V. L. M. A., … Creutzberg, C. L. (2020). PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 30(12), 2002–2007. https://doi.org/10.1136/ijgc-2020-001929
Vetter, M. H., Bixel, K., & Felix, A. S. (2020). Management of stage II endometrial cancer and subsequent oncologic outcomes: a National Cancer Database study. Journal of gynecologic oncology, 31(6), e84. https://doi.org/10.3802/jgo.2020.31.e84
Wang, W., Wang, T., Liu, Z., He, J., Sun, X., Zhong, W., Zhao, F., Li, X., Li, S., Zhu, H., Ma, Z., Hu, K., Zhang, F., Hou, X., Wei, L., & Zou, L. (2023). Practice patterns of adjuvant radiotherapy in women with stage I to II endometrial carcinoma: a real-world multi-institutional analysis in China. BMC women's health, 23(1), 417. https://doi.org/10.1186/s12905-023-02548-0
Wortman, B. G., Creutzberg, C. L., Putter, H., Jürgenliemk-Schulz, I. M., Jobsen, J. J., Lutgens, L. C. H. W., van der Steen-Banasik, E. M., Mens, J. W. M., Slot, A., Kroese, M. C. S., van Triest, B., Nijman, H. W., Stelloo, E., Bosse, T., de Boer, S. M., van Putten, W. L. J., Smit, V. T. H. B. M., Nout, R. A., & PORTEC Study Group (2018). Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy. British journal of cancer, 119(9), 1067–1074. https://doi.org/10.1038/s41416-018-0310-8
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 The Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Start-up >